Dialysis system with ultrafiltration control

Information

  • Patent Grant
  • 9545469
  • Patent Number
    9,545,469
  • Date Filed
    Monday, August 1, 2016
    8 years ago
  • Date Issued
    Tuesday, January 17, 2017
    8 years ago
Abstract
Systems and methods are disclosed for performing hemodialysis that include fluid handling systems that provide accurate control over the type and level of hemodialysis being performed. The system includes a first pump for pumping dialysate into a dialyzer and a second pump for pumping dialysate out of the dialyzer. The system also includes a third pump that provides improved control of a level of ultrafiltration, hemodiafiltration, or both.
Description
BACKGROUND

Chronic dialysis has been performed on patients with kidney failure since the early 1960's. A dialyzer is a device for cleansing blood through hemodialysis by a process of diffusion and/or convection of waste products, dissolved solutes and fluid from the blood across a semi permeable membrane into a dialysis solution known as dialysate. A dialysis system is an assembly that includes the dialyzer and associated equipment to support the dialyzer, such a plumbing and pumps.


Diffusion is the principal mechanism in which dialysis removes waste products such as urea, creatinine, phosphate and uric acid, among others, from the blood. A differential between the chemical composition of the dialysate and the chemical composition of the blood causes the waste products to be drawn through the semi-permeable membrane from the blood into the dialysate. Ultrafiltration is a process in dialysis where fluid is caused to move across the membrane from the blood into the dialysate for the purpose of removing excess fluid from the patient's blood stream. Along with water, some solutes are also drawn across via convection rather than diffusion. Ultrafiltration is a result of a pressure differential between the blood compartment of the dialyzer and the dialysate compartment of the dialyzer where fluid will move from a higher pressure to a lower pressure. In some circumstances, by design or unintentionally, fluid in the dialysate compartment is higher than the blood compartment, causing fluid to move from the dialysate compartment into the blood compartment. This is commonly referred to as reverse ultrafiltration.


It would be convenient for a patient to be able to perform dialysis in his or her home. Unfortunately, current dialysis systems are large in size, making them generally unsuitable for use in a patient's home. Current dialysis systems are also energy-inefficient in that they use large amounts of energy and require enormous amounts of water for proper use. Although some home dialysis systems are available, they generally use complex flow-balancing technology that is relatively expensive to manufacture and most systems are designed with a system of solenoid valves that create high noise levels. As a result, most dialysis treatments are performed at dialysis centers.


SUMMARY

In view of the foregoing, there is a need for improved dialysis systems that are smaller, more portable, consume less water and that provide precise control over a level of ultrafiltration. Disclosed are systems and methods for performing hemodialysis that include fluid handling systems and provide accurate control over the type and level of hemodialysis being performed. The system includes a first pump for pumping dialysate into a dialyzer and a second pump for pumping dialysate out of the dialyzer. The system also includes a third pump that provides improved control of a level of ultrafiltration, hemodiafiltration, or both, as described in detail below.


In one aspect, there is disclosed a method of performing dialysis, comprising: operating a first pump to pump dialysate at a first flow rate through a fluid inlet pathway into a dialyzer; operating a second pump to pump the dialysate through a fluid outlet pathway out of the dialyzer; operating a third pump to pump the dialysate through the fluid outlet pathway in cooperation with the second pump, wherein the second and third pumps cooperate to collectively achieve a second flow rate through the fluid outlet pathway from the dialyzer; and pumping blood through the dialyzer in communication with the dialysate such that the dialyzer dialyzes the blood.


In another aspect, there is disclosed a method of performing dialysis, comprising: providing a dialysis system having an inlet conduit through which fluid flows in an inward direction toward a dialyzer and an outlet conduit through which fluid flows in an outward direction from the dialyzer; pumping fluid through the inlet conduit using a first pump; pumping fluid through the outlet conduit using a second pump; and using a third pump to supplement the pumping of the second pump through the outlet conduit.


In another aspect, there is disclosed a dialysis system, comprising: a dialyzer having a blood flow pathway through which blood flows; a fluid inlet pathway configured to provide incoming fluid to the dialyzer; a fluid outlet pathway configured to receive outgoing fluid from the dialyzer; a first pump coupled to the fluid inlet pathway and configured to pump the fluid through the fluid inlet pathway toward the dialyzer; a second pump coupled to the fluid outlet pathway and configured to pump the fluid through the fluid outlet pathway away from the dialyzer; and a third pump coupled to the fluid outlet pathway, the third pump configured to work in cooperation with the second pump to achieve a desired flow rate of fluid to or from the blood flowing through the dialyzer.


Other features and advantages should be apparent from the following description of various embodiments, which illustrate, by way of example, the principles of the disclosed devices and methods.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1A shows a schematic view of a dialysis system adapted to perform dialysis of a patient's blood.



FIG. 1B shows a schematic view of another embodiment of a dialysis system.



FIG. 2 is a schematic view of a dialyzer of the dialysis system.



FIG. 3 shows a schematic representation of the system running in a calibration mode.



FIG. 4 shows a schematic representation of the system running in a dialysis mode.



FIG. 5 is a cross-sectional view of a compliance control device.



FIG. 6 is a cross-sectional view of another embodiment of a compliance control device.





DETAILED DESCRIPTION

In order to promote an understanding of the principals of the disclosure, reference is made to the drawings and the embodiments illustrated therein. Nevertheless, it will be understood that the drawings are illustrative and no limitation of the scope of the disclosure is thereby intended. Any such alterations and further modifications in the illustrated embodiments, and any such further applications of the principles of the disclosure as illustrated herein are contemplated as would normally occur to one of ordinary skill in the art.



FIG. 1A shows a schematic view of a dialysis system adapted to perform hemodialysis of a patient's blood. The system includes an arrangement of three or more pumps that provide improved control over the type of hemodialysis being performed. By varying the relative pump speeds of the three pumps, an operator can vary the level of blood filtration and can also selectively achieve ultrafiltration and hemodiafiltration of the blood.


Ultrafiltration is a process in dialysis where fluid is caused to move across a dialyzer membrane via diffusion from the blood into the dialysate for the purpose of removing excess fluid from the patient's blood stream. Along with water, some solutes are also drawn across the membrane via convection rather than diffusion. Ultrafiltration is a result of a pressure differential between the blood compartment and the dialysate compartment where fluid will move from a higher pressure to a lower pressure.


In some circumstances, by design or unintentional, fluid in the dialysate compartment is higher than the blood compartment causing fluid to move from the dialysate compartment into the blood compartment. This is commonly referred to as reverse ultrafiltration. In hemodiafiltration a high level of ultrafiltration is created, greater than the amount required to remove fluid from the patient's blood, for the purpose of increasing convective solute transport across the membrane. The amount of fluid in excess of what is required to be removed from the patient's blood must therefore be returned to the blood stream in order to avoid an adverse blood reaction. This is accomplished by intentionally increasing the pressure in the dialysate compartment of the dialyzer to cause the appropriate amount of reverse ultrafiltration. This process of ultrafiltration alternating with reverse ultrafiltration is often referred to as “push-pull hemodiafiltration”. This is a significant improvement over more common methods of hemodiafiltration where sterile fluid is administered to the patient in a location outside of the dialyzer.


The dialysis system includes a dialyzer 105 that is fluidly connected to a source 110 of fluid (such as dialysate) and also to a source 115 of blood to be dialyzed. The source 115 of blood may be a patient. The source 110 of fluid may be a dialysate preparation system that prepares dialysate for use in the dialysis system. The dialysate preparation system may include a water purification system that purifies water pursuant to systems and methods described in U.S. patent application Ser. No. 12/795,382, entitled “Fluid Purification System”, filed Jun. 7, 2010, now U.S. Pat. No. 8,501,009, and which is incorporated by reference in its entirety. In addition, the dialyzer 105 may be at least partially configured with microfluidic pathways as described in U.S. patent application Ser. No. 12/795,371 entitled “Microfluidic Devices”, filed Jun. 7, 2010, which claims priority to U.S. Provisional Application No. 61/220,117, filed Jun. 24, 2009, which applications are incorporated by reference in their entirety. U.S. patent application Ser. No. 12/795,444 entitled “Dialysis System”, filed Jun. 7, 2010, now U.S. Pat. No. 8,801,922, is also incorporated by reference in its entirety. Dialysate flows into the dialyzer 105 through a fluid inlet 120 and out of the dialyzer 105 through a fluid outlet 125. Blood flows through the dialyzer 105 via a blood flow pathway 124 that includes a blood inlet 130 into the dialyzer 105 and a blood outlet 133 out of the dialyzer. From the dialyzer 105, the blood flows back to the patient. The dialyzer 105 is described in more detail below.


The dialysis system includes plumbing that forms a plurality of fluid flow pathways, which may be any type of conduit through which a fluid such as dialysate may flow. The fluid flow pathways include an inlet pathway 132 through which a fluid such as unused dialysate flows from the source 110 toward and into the dialyzer 105. At least a first pump 135 is positioned along or in communication with the inlet pathway 132 for pumping the fluid toward the dialyzer 105 at a desired flow rate. One or more sensors S may be coupled to the fluid flow pathway for sensing one or more characteristics of the incoming fluid, such as pressure, flow rate, temperature, conductivity, etc. In addition, one or more sample ports P may be coupled to the fluid flow pathways that provide access to fluid flowing through the piping. FIG. 1 shows the sensors S and sample ports P coupled to the fluid flow pathways at specific locations, although the quantity and locations of the sensors S and sample ports P may vary.


The fluid flow pathways further include an outlet pathway 137 through which used dialysate flows out of the dialyzer 105 toward one or more drains 140. In some embodiments, the dialysate exiting the dialyzer may be used to pre-heat other incoming fluids in the system, such as the water stream entering the heat exchange and purification system, before reaching the drain 140. The outlet pathway 137 bifurcates into two or more outlet pathways including a main outlet pathway 137a and a secondary outlet pathway 1137b. At least a second pump 155 is positioned along or in communication with the main outlet pathway 137a for pumping the dialysate out of and away from the dialyzer 105 through the main outlet pathway 137a.


A third pump 160 is positioned along or in communication with the secondary outlet pathway 137b. The third pump 160 can be used to augment fluid flow through the fluid flow pathways such as to selectively achieve differentials in flow rates between the inflow pathway 132 and the outflow pathway 132 pursuant to achieving various types of dialysis, including hemodialysis, ultrafiltration, and hemodiafiltration, as described more fully below. The third pump pumps dialysate through the fluid flow pathways when the system is in dialysis mode. The third pump may also pump another fluid, such as water or disinfectant, when the system is in a different mode, such as in a calibration mode or in a cleaning mode. The third pump 160 can also be used to calibrate flow rates between the first pump 135 and the second pump 155, as described more fully below.


In another embodiment, shown in FIG. 1B, the third pump 160 is positioned along the inflow pathway 132 upstream of the inlet 120 of the dialyzer 105. In this embodiment, the secondary outlet pathway 137 branches off the inlet pathway 132 at a location downstream of the first pump 135 and upstream of the first valve 170. The third pump 160 pumps fluid toward the drain 140. The embodiment of FIG. 1A may be more efficient than the embodiment of FIG. 1B because the third pump 160 in FIG. 1B pumps fresh, unused dialysate into the drain 140 while the third pump in FIG. 1A pumps used dialysate into the drain 140. In another embodiment, the third pump 160 and the second pump 155 are both positioned along a single, non-bifurcating outflow pathway.


Various types of pumps may be used for the first, second and third pumps. In an embodiment, the pumps are nutating pumps. On other embodiments, the pumps could be rotary lobe pumps, progressing cavity pumps, rotary gear pumps, piston pumps, diaphragm pumps, screw pumps, gear pumps, hydraulic pumps, vane pumps, regenerative (peripheral) pumps, or peristaltic pumps, or any combination thereof. Other types of pumps can also be used. The first pump 135 and the second pump 155 may be driven by a common shaft to ensure synchrony of the pump strokes and the volume of fluid pumped. It is understood that first pump 135 and the second pump 155 may also be fully independent from each other.


As mentioned, any of a variety of fluid conduits may be used to form the fluid flow pathways. In an embodiment, at least a portion of the fluid flow pathway is formed of piping having an inside diameter from ⅛ inch to ½ inch. The flow rate in the piping could range between about 50 ml/min to about 1,000 ml/min. In an embodiment, the flow rate is in the range of between about 100 ml/min and about 300 ml/min.


With reference again to FIG. 1A, the fluid flow pathways further include a bypass pathway 165 that fluidly directly connects the inlet pathway 132 and the outlet pathway 137. An exemplary purpose of the bypass pathway 165 is to provide a fluid flow pathway where fluid can flow into and out of the dialysis system and bypass the dialyzer 105, such as for flushing, cleaning or calibrating the system. In an embodiment, the junction between the inlet pathway 132 and bypass pathway 165 is located upstream of the fluid inlet 120 of the dialyzer 105, and the junction between the bypass pathway 165 and the outlet pathway is located downstream of the fluid outlet 125 of the dialyzer 105. However, other configurations of the bypass pathway 165 can be used to achieve bypassing of the dialyzer 105.


A first valve 170 is positioned at the junction between the inlet pathway 132 and the bypass pathway 165. A second valve 175 is positioned at the junction between the bypass pathway 165 and the outlet pathway 137. The first valve 170 and second valve 175 are three-way valves, such as solenoid valves, that can be used to selectively regulate fluid flow through the fluid flow pathways. That is, the first valve 170 can be set to either of two or more settings including (1) a dialysis setting wherein the first valve directs all incoming fluid along the inlet pathway 132 toward the dialyzer 105 (as represented by arrow A in FIG. 1) and prevents incoming fluid from flowing into the bypass pathway 165; or (2) a bypass setting wherein the first valve 170 diverts all the incoming fluid into the bypass pathway 165 (as represented by arrow B in FIG. 1) and the prevents incoming fluid from flowing past the first valve toward the dialyzer 105.


The second valve 175 can also be set to either of two settings including (1) a bypass setting wherein the second valve 175 directs incoming fluid from the bypass pathway 165 into the outlet pathway 137 (as represented by arrow C in FIG. 1); or (2) a dialysis setting wherein the second valve 175 closes flow from the bypass valve 165 such that outgoing fluid from the dialyzer outlet 125 continues to flow outward along the outlet pathway 137 (as represented by arrow D in FIG. 1.) The first valve 175 and the second valve 160 are generally both set in tandem to either the bypass setting or the dialysis setting. The system may include a control and safety system that ensures that the first and second valves are not set to incompatible settings.


The arrangement of the various components of the dialysis system shown in FIGS. 1A and 1B are exemplary and other arrangements are possible. For example, the flow pathways and the pumps may be placed in different locations along the flow pathways from what is shown in FIG. 1. In an embodiment, the third pump 160 is positioned in the flow pathway at a location upstream of the dialyzer 105 and downstream of the first valve 170 or the third pump can be positioned downstream of the dialyzer 105 and upstream of the second valve 175. Moreover, the system can employ more than three pumps.


Dialyzer and Various Forms of Dialysis



FIG. 2 is a schematic, cross-sectional view of the dialyzer 105, which defines a blood compartment having a blood flow pathway 205 and a dialysate compartment having a dialysate flow pathway 210 separated by a semi-permeable membrane 215. The blood (from a patient) enters the blood flow pathway 205 via the blood inlet 130, flows through the blood flow pathway 205, and exits via the blood outlet 133. The dialysate enters the dialysate flow pathway 210 via the fluid inlet 120, flows through the dialysate flow pathway 210, and exits via the fluid outlet 125. The semi-permeable membrane 215 is configured to allow the transfer of one or more substances from the blood in the blood flow pathway 205 to the dialysate in the dialysate flow pathway 210, or visa-versa. Some examples of materials that may be used as the semipermeable membrane 215 include polymers, copolymers, metals, ceramics, composites, and/or liquid membranes. One example of a composite membrane is polysulfone-nanocrystalline cellulose composite membrane such as AN69 flat sheet membranes available from Gambro Medical. Gas-liquid contactor membranes may also be employed for transferring a substance between a liquid and gas such as for oxygenation of blood, whereby the membrane allows transfer of carbon dioxide and oxygen, such that oxygen transfers to blood from oxygen or oxygen-enriched air, and carbon dioxide transfers from the blood to the gas. Fluid membranes may also be employed. Fluid membranes comprise a lamina having through cut microchannels containing fluid and a first and second membrane support positioned to contain fluid in the microchannels.


When flowing through the dialyzer 105, the blood and the dialysate may flow in a counter-flow configuration wherein blood flows through the blood flow pathway 205 in one direction and the dialysate flows through the dialysate flow pathway 210 in the opposite direction. The dialyzer 105 is described in the context of having a counter-flow configuration although a cross-flow configuration may also be used. As the blood and water flow along the membrane 215, hemodialysis occurs. That is, waste solutes move across the semipermeable membrane 215 from the blood into the dialysate via diffusion as a result of the differential of solute concentration between the blood and the dialysate. The flow of the blood and dialysate, which may be counter-, cross- or concurrent-flow, maintains the concentration gradient of solutes between the blood and dialysate, which helps to remove more urea and creatinine from the blood. The concentrations of solutes (for example potassium, phosphorus, and urea) may be undesirably high in the blood, but low or absent in the dialysate and constant replacement of the dialysate ensures that the concentration of undesired solutes is kept low on the dialysate side of the membrane. The dialysate has levels of minerals like potassium and calcium that are similar to their natural concentration in healthy blood. For another solute, bicarbonate, the dialysate level is set at a slightly higher level than in normal blood, to encourage diffusion of bicarbonate into the blood, to maintain a patient's CO2 level, and act as a pH buffer to neutralize the metabolic acidosis that is often present in these patients.


The dialyzer 105 is also configured to perform ultrafiltration wherein a pressure differential across the membrane 215 results in fluid and dissolved solutes passing across the membrane 215 from the blood to the dialysate.


The dialyzer 105 is also configured to perform hemodiafiltration wherein solute movement across the semipermeable membrane 215 is governed by convection rather than by diffusion. A positive hydrostatic pressure differential between the blood flow pathway 205 and the dialysate flow pathway 210 drives water and solutes across the semipermeable membrane 215 from the blood flow pathway to the fluid flow pathway. Solutes of both small and large molecules get dragged through the semipermeable membrane 215 along with the fluid. In a typical hemodiafiltration procedure, the direction of water and solute movement is oscillated between moving water and solutes from the blood into the dialysate and moving water and solutes from the dialysate into the blood. Over a predetermined span of time, there is a net zero loss and zero net gain of fluid from the blood into the dialysate. However, during discrete time periods within that span of time, there can be a net loss of fluid from the blood into the dialysate and a net gain of fluid into the blood from the dialysate.


Operation of Pumps to Achieve Hemodialysis without Ultrafiltration


With reference again to FIG. 1A, the dialysis system achieves hemodialysis without ultrafiltration when the flow rate through the inlet pathway 132 is equal to or substantially equal to the flow rate through the outlet pathway 137. In other words, hemodialysis without ultrafiltration is achieved where the amount of dialysate flowing into dialyzer 105 via the inlet pathway 137 is substantially equal to the amount of dialysate flowing out of the dialyzer via the outlet pathway 137 over a period time. This can be achieved by operating the first pump 135 at a first pump rate to provide a first flow rate through the inlet pathway 132 and operating the second pump 155 and the third pump 160 at respective pump rates that collectively achieve a flow rate through the outlet pathway 137 that is equal to the flow rate through the inlet pathway 132.


In an embodiment, the system performs a hemodialysis procedure utilizing all three pumps in an active state substantially continuously throughout the hemodialysis procedure. The system adjusts the pump rate of the third pump 160 to achieve a desired balance of equal flow rates between the inlet pathway 132 and the outlet pathway 137. In this embodiment, the first pump 135, second pump 155, and third pump 160 are all active throughout the hemodialysis procedure with the first and second pumps operating at different pump rates and the third pump operating at a pump rate that achieves a balanced flow rate between the inlet pathway 132 and the outlet pathway 136. The third pump is typically operated at a pump rate that is equal to the differential between the pump rate of the first pump and the pump rate of the second pump. In this manner, the second and third pumps collectively achieve a flow rate through the outlet pathway 137 that is equal to the flow rate through the inlet pathway 132.


For example, to achieve a desired flow rate of, for example, 100 ml/min through the dialyzer, the first pump 135 is set to provide a flow rate of 100 ml/min through the inlet pathway 132 and the second pump 155 is deliberately set out of balance with the first pump 135, to provide, for example, a flow rate of only 80 ml/min. This would provide a flow rate differential of 20 ml/min between the first pump and the second pump. The pump rate of third pump 160 is set to provide a flow rate of 20 ml/min, which is equal to the differential between the flow rates of the first and second pumps. In this manner, the second pump 155 and the third pump 160 collectively achieve a flow rate of 100 ml/min through the outlet pathway 137 which is equal to the flow rate of through the inlet pathway 132 such that the flow rates are balanced across the dialyzer. Under such conditions, waste solutes move across the dialyzer's semipermeable membrane from the blood stream into the dialysate via diffusion to perform hemodialysis.


The flow rates through the inlet pathway 132 and the outlet pathway 137 may be measured using one or more of the sensors S. In an embodiment, the sensors are flow rate sensors that directly measure flow rates through the inlet pathway 132 and outlet pathway 137. In another embodiment, the sensors are pressure sensors that provide indications as to the fluid pressure within the inlet pathway 132 and the fluid pressure within the outlet pathway 137. Fluid pressure is a function of the flow rate through the flow pathways and therefore provides an indirect measurement of flow rate. Where the fluid pressure in the inlet pathway 132 is equal to the fluid pressure in the outlet pathway 137, this is an indication that the flow rates are balanced between the inlet pathway and outlet pathway. Where the fluid pressure in the inlet pathway 132 is less than the fluid pressure through the outlet pathway 137, this is an indication that the flow rate through the inlet pathway 132 is less than the flow rate through the outlet pathway 137. Where the fluid pressure in the inlet pathway 132 is greater than the fluid pressure through the outlet pathway 137, this is an indication that the flow rate through the inlet pathway 132 is greater than the flow rate through the outlet pathway 137. The system of fluid pathways may include one or more damping mechanisms for dampening any extreme fluctuations in pressure within the fluid pathways.


In the latter two situations, the pump rate of the third pump 160 may be adjusted in response to a pressure differential between the inlet and outlet pathways such as in a calibration procedure, to achieve a balanced flow rate between the inlet pathway 132 and outlet pathway 137. The calibration procedure may optionally be performed with the system in a calibration mode such that the first and second valves are set to cause fluid to flow through the bypass pathway 165 and bypass the dialyzer 105, as represented in FIG. 3 and described in more detail below. When the calibration procedure is performed by bypassing the dialyzer 105 and a pressure differential is detected between the inlet and outlet pathways, the flow of the third pump 160 may be appropriately adjusted ‘on the fly’ to increase or decrease the third pump's speed to achieve the desired flow rate in the outlet pathway 137 without having to turn the pump on or off. In this regard, the pressure sensors S and the three pumps, as well as the valves 175, may be connected in a closed loop control system to achieve automatic balancing of the flow rates.


In another embodiment, a balanced flow rate between the inlet pathway 132 and the outlet pathway 137 is achieved in theory at least by the first pump 135 and the second pump 155 operating at the same pump rate to achieve equal flow rates through the inlet pathway 132 and outlet pathway 137. Although it is theoretically possible to match the flow rates of the first pump 135 and the second pump 137, various factors may result in the actual fluid flow rate in the inlet pathway 132 differing from the actual fluid flow rate in the outlet pathway 137. The factors may include trapped air, hardware wear, and fluid leakage, which can cause the flow rates of the first and second pumps to diverge over time from a preset or desired value. Typical technologies in dialysis systems are unable to correct the flow balance for these types of factors.


Thus, there may come a time when a balanced flow rate cannot easily be achieved through use of the first and second pumps alone, and thus when there exists a need for correction to equalize the flow rates between the inlet pathway 132 and outlet pathway 137. Where the fluid flow rates are different, the third pump 160 can be used to correct the differing flow rates by being activated to pump fluid through the secondary outlet pathway 1137b at a rate that is equal to the delta between the fluid flow rate through the inlet pathway 132 and the fluid flow rate through the outlet pathway 137. The system is preferably configured such that the first pump 135 is prevented from pumping less fluid than the second pump 155 such that the first pump 135 always pumps at a higher rate than the second pump 155. The system preferably includes a control system that detects a condition where the first pump 135 inadvertently pumps at a slower rate than the second pump 155 and sets off an alarm or moves the system out of dialysis mode if such a situation occurs.


According to a flow rate correction process, the sensors S (FIG. 1) are used to measure the flow rates through the inlet pathway 132 and the outlet pathway 137. A comparison is performed between the flow rate through the inlet pathway 132 and the flow rate through the outlet pathway 137. Where the flow rates are different, the third pump 160 is activated from a de-activated state to cause fluid to flow into the secondary outlet pathway 137b at a rate selected to cause the overall flow rate in the outlet pathway 137 to be equal to the flow rate in the inlet pathway 132. A mechanism such as a servo mechanism may be used to adjust the stroke volume of the first pump 135 and/or the second pump 155 until balance of the flow rates is restored (as may be evidenced, for example, by the presence of the same fluid pressure in both the inlet pathway 132 and the outlet pathway 137).


As mentioned, the sensors S may be communicatively coupled to a control system and to the three pumps in a closed loop system. The control system includes hardware and/or software that automatically activates and/or deactivates the third pump 160 or adjusts the pump rate of the third pump 160 as needed in response to differences in detected flow rates from predetermined values or from each other, to equalize the flow rates between the inlet pathway 132 and outlet pathway 137. It should be appreciated that other measurements, such as fluid pressure in the inlet and outlet pathways, may be used to indirectly calculate the flow rates rather than directly measuring the flow rates. In this regard, the fluid pressures within the inlet pathway and the outlet pathway may be measured for any detectable change in pressure from a predetermined value or from each other. The flow pathways may be adapted to be essentially non-compliant so that a small difference in the flow rates of the first pump 135 and the second pump 155 will cause a rapid pressure change either negative or positive in magnitude.


The system may initially and/or periodically run in a calibration mode (sometimes also referred to as a UF checking mode) wherein a fluid (which may or may not be dialysate) is flowed through the flow pathways with the first valve 170 and second valve 137 set to the “bypass setting” such that fluid flowing through the system bypasses the dialyzer 105 via the bypass pathway 165. FIG. 3 shows a schematic representation of the system running in such a calibration mode where the dialyzer 105 is bypassed. In the embodiment where the system utilizes all three pumps in an active state substantially continuously throughout the hemodialysis procedure, the first and second pumps are initially deliberately set to achieve unbalanced flow rates. The sensors S in the flow pathway are then used to measure the fluid flow rate or pressure through the inlet pathway and the fluid flow rate or pressure through the outlet pathway. The third pump 160 is then set at a pump speed that achieves a substantially balanced flow rate between the inlet pathway 132 and outlet pathway 137.


In the other embodiment, the first pump 135 and second pump 155 are initially set to achieve equal flow rates without necessarily requiring the assistance of the third pump 160, which is initially inactive. The sensors S in the flow pathway are then used to measure the fluid flow rate through the inlet pathway and the fluid flow rate through the outlet pathway. Where the fluid flow rates are equal, the third pump 160 remains inactive. However, where the fluid flow rates are not equal, the third pump 160 is run at a rate that compensates for the discrepancy in flow rates between the inlet pathway 132 and outlet pathway 137. As mentioned, the third pump 160 may operate in a closed-loop relationship with the flow rate sensors and/or the pressure sensors. FIG. 3 shows the third pump 160 in phantom lines to represent the third pump may or may not be activated depending on whether there is a flow rate differential between the inlet pathway 132 and outlet pathway 137. The calibration procedure that does not require activating and de-activating the third pump is preferred as the system may run more efficiently when all three pumps are continuously operating.


After the calibration procedure is completed, the valves 170 and 175 may be set to the “dialysis setting” such that fluid flows from the source 110, through the inlet pathway 132, into the dialyzer 105, out of the dialyzer, and into the outlet pathway 137 from the dialyzer 105. When configured as such, the system can be used for dialysis by flowing dialysate into and out of the dialyzer 105 via the inlet and outlet pathways, and by also by flowing blood into and out of the dialyzer via the blood flow pathway 124. During dialysis, the previously described calibration procedure may be periodically repeated, such as at predetermined intervals, to ensure that the flow rates of the inlet and outlet pathways remain within desired ranges.


In an embodiment, calibration is run only at the beginning of a dialysis session. In a more preferred embodiment, calibration is run periodically during the dialysis session, to ensure that the desired flow balance is maintained throughout the session. The control system can cycle the valves 170 and 175 controlling incoming flow stream between the dialysis setting and the bypass setting and run the calibration steps without additional interruptions to the dialysis session. During the calibration process, when the dialysate fluid bypasses the dialyzer 105, dialysis of the blood that passes through the dialyzer during that period of time is unhampered due to no fresh dialysate being provided to the dialyzer 105, though the blood may cool slightly. As long as the calibration step can be conducted over a relatively short period of time relative to the time between calibrations, the calibration has no material effect on the quality of dialysis being provided to the patient. In an embodiment, the dialysis system can be cycled between calibration for one minute followed by 60 minutes of dialysate being delivered through the dialyzer. In another embodiment, the dialysis system can be cycled between calibration for 30 seconds followed by 120 minutes of dialysate being delivered through the dialyzer. Various different cycle times between calibration and dialysis may be chosen based on how frequently the system's calibration is to be verified and/or adjusted. If no adjustment to any of the pumps is necessary during calibration, the calibration step may be concluded in a much shorter period of time than 30-seconds, for example 5-10 seconds.



FIG. 4 schematically shows the system running in a dialysis mode. The third pump 160 and the flow arrow 405 through the secondary outlet pathway 137b are shown in phantom lines to indicate that the third pump 160 may or may not be active while the system is in dialysis mode. The third pump 160 may be active in the situation where the third pump 160 is needed to equalize the flow rates between the inlet pathway and outlet pathways. Or, the flow rates of the inlet and outlet pathways may be equal without the assistance of the third pump 160, in which case the third pump 160 remains inactive.


Operation of Pumps to Achieve Ultrafiltration


The dialysis system achieves ultrafiltration in the situation where the flow rate through the inlet pathway 132 differs from the flow rate through the outlet pathway 137 such that there is an unbalanced flow rate across the dialyzer. Where the flow rate through the outlet pathway 137 is greater than the flow rate through the inlet pathway 132, the dialyzer 105 pulls fluid from the blood across the semipermeable membrane by a convective process in order to compensate for the unbalanced flow rate. In an embodiment, the system utilizes all three pumps substantially continuously throughout the procedure and the pump rate of the third pump 160 is adjusted to achieve a desired flow rate differential between the inlet pathway 132 and the outlet pathway 137 to perform ultrafiltration. That is, the first pump 135, second pump 155, and third pump 160 are all active with the first and second pumps operating at different pump rates. The third pump is then operated at a pump rate that intentionally achieves a desired imbalance of flow rates between the inlet pathway 132 and the outlet pathway 136 sufficient to cause ultrafiltration.


For example, to achieve the removal of fluid at a rate 10 ml/min from the blood stream, the first pump 135 is set to provide a flow rate of 100 ml/min through the inlet pathway 132 and the second pump 155 is deliberately set out of balance with the first pump 135, to provide, for example, a flow rate of only 80 ml/min. The third pump 160 is then set to provide a flow rate of 30 ml/min such that the second and third pumps collectively provide a flow rate of 110 ml/min through the outlet pathway 137. With a flow rate of 100 ml/min through the inlet pathway 132 and a flow rate of 110 ml/min through the outlet pathway, the dialyzer 105 compensates for the 10 ml/min flow rate differential by transferring 10 ml/min of fluid from the blood stream into the dialysate.


In another example, to achieve the addition of fluid at a flow rate of 10 ml/min into the blood stream, the first pump 135 is set to provide a flow rate of 100 ml/min through the inlet pathway 132 and the second pump 155 is again deliberately set out of balance with the first pump 135, to provide, for example, a flow rate of only 80 ml/min. The third pump 160 is then set to provide a flow rate of only 10 ml/min such that the second and third pumps collectively provide a flow rate of 90 ml/min through the outlet pathway 137. With a flow rate of 100 ml/min through the inlet pathway 132 and a flow rate of 90 ml/min through the outlet pathway, there is a transfer of 10 ml/min from the dialysate into the blood stream in order to compensate for the flow rate differential. It should be appreciated that the flow rate values in the preceding examples and following examples are only for purpose of example and that the actual flow rates as well as the relative flow rates can vary to achieve a desired level of ultrafiltration or reverse ultrafiltration.


The speed of the third pump 160 can be varied to selectively vary an amount of ultrafiltration. For example, if it is determined that the ultrafiltration is greater than desired when pulling fluid out of the blood, for example, the pump speed of the third pump 160 can be slowed down, reducing the amount of extra fluid that the third pump 160 draws out of the dialyzer. Where the ultrafiltration is not great enough when compared against a desired predetermined value, the pump speed of the third pump 160 may be increased in the case where fluid is being pulled out of the blood into the dialysate, for example, to draw an even greater amount of fluid out of the dialyzer and, hence, the blood.


In another embodiment, the third pump 160 may be coupled to a source of fluid such that the third pump 160 outputs extra fluid into the flow pathway via the secondary outlet pathway 137b, such as in the embodiment of FIG. 1B. The extra fluid introduced into the flow pathway is transferred across the semi-permeable membrane 215 into the blood.


Operation of Pumps to Achieve Hemodiafiltration


The dialysis system is configured to achieve hemodiafiltration by oscillating the speed of the third pump between (1) a first speed such that the second and third pump collectively achieve a flow rate through the outlet pathway that is greater than the flow rate through the inlet pathway; and (2) a second speed such that the second and third pump collectively achieve a flow rate through the outlet pathway that is less than the flow rate through the inlet pathway. In this manner, the third pump 160 can be used to intermittently alternate the flow rate differential between a state where the dialyzer 105 pulls fluid from the blood stream into the dialysate and a state where the dialyzer 105 pushes fluid from the dialysate into the blood stream. Over a predetermined span of time, there should be a zero net loss (or substantially a zero net loss) of fluid from the blood and a zero net gain (or substantially a zero net gain) of fluid into the blood for the process of hemodiafiltration. However, during that span of time, the dialyzer 105 periodically transfers fluid into the blood from the dialysate and periodically transfers fluid out of the blood into the dialysate. If ultrafiltration is desired to be performed at the same time as the hemodiafiltration, then the pumps can be operated in such a way so that in addition to the cycling of fluid into and out of the blood over time, there also occurs a net gain or loss of fluid to or from the blood over a predetermined span of time.


For example over an exemplary time span of ten minutes, the first pump 135 is set to provide a flow rate of 100 ml/min through the inlet pathway 132 and the second pump 155 is again deliberately set out of balance with the first pump 135, to provide, for example, a flow rate of only 80 ml/min. The speed of pump 160 can be cycled between a rate of 10 ml/min for a period of 30 seconds and 30 ml/min for a period of 30 seconds. During the periods when the speed of the third pump 160 is at a rate of 10 ml/min, the total flow rate through the outlet pathway 137 is 90 ml/min with the flow rate through the inlet pathway 132 at 100 ml/min, resulting in an unbalanced flow rate that causes the dialyzer 105 to transfer 10 ml/min of fluid into the blood stream. During the periods when the speed of the third pump 160 is at a rate of 30 ml/min, the total flow rate through the outlet pathway 137 is 110 ml/min with the flow rate through the inlet pathway 132 at 100 ml/min, resulting in an unbalanced flow rate that causes the dialyzer 105 to transfer 10 ml/min of fluid from the blood stream into dialysate. Over the span of ten minutes with alternating periods of 30 seconds as described above, there is a net balanced flow rate of 100 ml/min across the dialyzer without any net addition or subtraction of fluid from the blood. This serves the purpose of passing fluid to the blood across the membrane and then fluid from the blood to the dialysate across the membrane to achieve hemodiafiltration of the blood and increases the removal of large-molecular waste products that would not otherwise be effectively dialyzed. In this way, operation of the three or more-pump system can achieve all of hemodialysis, ultrafiltration and hemodiafiltration through how the speeds of the first, second, and third pumps are controlled. This type of operation has heretofore not been possible in other dialysis systems.


In another embodiment, shown in FIG. 1B, the third pump is located on the inlet flow side of the dialyzer instead of on the outlet flow path, such that the first and third pumps collectively achieve the desired inlet flow rate and the second pump achieves the desired outlet flow rate to perform one or more of hemodialysis, ultrafiltration and hemodiafiltration.


Between dialysis treatments, the flow pathways may be rinsed and/or disinfected. A rinse fluid, such as, but not limited to disinfectant solution and water, is routed through the flow pathways while the valves are in the bypass setting. During rinse mode, the third pump 160 may or may not be operated with the first pump 135 and second pump 155 to achieve fluid flow through the system.


Control of Flow Rates Using Pulsatile Pumps


In embodiments wherein the flow through flow pathways has a pulsatile nature, such as might be produced by certain types of pumps, the inherently high sensitivity of the methods described above might provide a challenge for controlling the flow rate as the small diameter and largely non-compliant flow pathways coupled with the pulsatile nature of the flow may make it difficult to measure pressures and pressure change rates sufficient to control the flow during dialysis.


In an embodiment, the pulsatile pressure signals present in a pulsatile flow configuration may be filtered out using appropriate signal conditioning. But the small volume and rigid flow pathways might cause too rapid of a pressure shift, quickly driving the pressure magnitude beyond the range of the pressure sensors. This may be particularly true for large, temporary mismatches associated with air being present in the flow pathways.



FIG. 5 is a cross-sectional view of a compliance control device 500 that may be positioned in fluid communication with the flow pathways of the system. The device 500 is adapted to smooth out the pulsatile nature of the flow. The compliance control device 500 comprises a chamber 505 divided by a compliant diaphragm 510 defining a first chamber 515 and a second chamber 520. The first chamber 505 comprises a first chamber inlet 525 and a first chamber outlet 530 adapted for fluid communication with the flow pathways of the system. The second chamber 520 is in fluid communication with a control valve 535 and air plenum 540, wherein a non-compliant fluid 545, such as, but not limited to an inert liquid or gel, is disposed in the second chamber 520 and a compliant gas 550 is disposed in the air plenum 540.


When the dialysis system is performing hemodialysis, the control valve 535 may be closed restricting the flow of the non-compliant fluid 545 to the second chamber 520 creating a substantially non-compliant flow circuit as the compliant diaphragm 510 is restricted from complying (elastically deforming) against the now relatively rigid non-compliant fluid 545.


During calibration of the dialysis system, the control valve 535 may be opened, allowing the non-compliant fluid 545 to react with the gas 550 in the air plenum in reaction to pressure transients of the fluid in the pathway acting against the diaphragm 510. The diaphragm 510 moves in response to the pressure change and the gas 550 in the air plenum tends to moderate and smooth the pressure changes, allowing for a more precise pressure detection during calibration for flow compensation by the third pump 160.



FIG. 6 is a cross-sectional view of another compliance control device 600 adapted for fluid communication with the flow pathways of the system and adapted to smooth out the pulsatile nature of the flow such as during calibration. The compliance control device 600 comprises a chamber 605 divided by a compliant diaphragm 510 defining a first chamber 610 and a second chamber 615. The first chamber 610 comprises a first chamber inlet 620 and a first chamber outlet 625 adapted for fluid communication with the flow pathways of the system. The second chamber 615 comprises a second chamber inlet 630 and a second chamber outlet 635 adapted for fluid communication with a source of non-pulsatile flow of substantially non-compliant fluid 640. The fluid flow into the second chamber inlet 630 is controlled by a control valve 535 and the second chamber outlet 635 is in fluid communication with a drain.


During hemodialysis operation of the system, the control valve 535 is opened, allowing the flow of non-compliant fluid 640 to flow into the second chamber 615 and against the diaphragm 510 which restricts the movement of the diaphragm 510 and therefore creates a substantially non-compliant flow circuit. During calibration of the system, the control valve 535 is closed, restricting the flow of the non-compliant fluid 640 into the second chamber 615 with the non-compliant fluid 640 left in the second chamber 615 free to flow to the drain. Without the flow of non-compliant fluid 640 reacting against the diaphragm 510 and the remaining fluid 640 in the second chamber 615 free to drain, the fluid can react against the diaphragm 510 unconstrained by the non-compliant fluid 640. The diaphragm 510 elastically moves in response to any pressure change in the flow circuit moderating and smoothing the pressure change, allowing for a more precise pressure detection in the flow pathways for flow compensation by the third pump 160.


It is appreciated that the compliance control devices 500 and 600, such as provided in FIGS. 5 and 6, can be placed in fluid communication at any location in the flow pathways of the system such as upstream of the first valve 170 and downstream of the second valve 175, suitable for a particular purpose.


While this specification contains many specifics, these should not be construed as limitations on the scope of an invention that is claimed or of what may be claimed, but rather as descriptions of features specific to particular embodiments. Certain features that are described in this specification in the context of separate embodiments can also be implemented in combination in a single embodiment. Conversely, various features that are described in the context of a single embodiment can also be implemented in multiple embodiments separately or in any suitable sub-combination. Moreover, although features may be described above as acting in certain combinations and even initially claimed as such, one or more features from a claimed combination can in some cases be excised from the combination, and the claimed combination may be directed to a sub-combination or a variation of a sub-combination. Similarly, while operations are depicted in the drawings in a particular order, this should not be understood as requiring that such operations be performed in the particular order shown or in sequential order, or that all illustrated operations be performed, to achieve desirable results.


Although embodiments of various methods and devices are described herein in detail with reference to certain versions, it should be appreciated that other versions, embodiments, methods of use, and combinations thereof are also possible. Therefore the spirit and scope of the appended claims should not be limited to the description of the embodiments contained herein.

Claims
  • 1. A method of calibrating a dialysis system comprising a dialyzer, a dialysate inlet pump, an inlet fluid flow pathway extending from the dialysate inlet pump to the dialyzer, a dialysate outlet pump, an outlet fluid flow pathway extending from the dialyzer to the dialysate outlet pump, the dialysate outlet pump being the only pump positioned for pumping dialysate out of and away from the dialyzer through the outlet fluid flow pathway, a bypass fluid flow pathway extending from the inlet fluid flow pathway to the outlet fluid flow pathway and bypassing the dialyzer, the method comprising: flowing fluid from the dialysate inlet pump through the bypass fluid flow pathway to the dialysis outlet pump;comparing pressure of the fluid in the inlet fluid flow pathway to pressure of the fluid in the outlet fluid flow pathway;based on a result of the comparing step, adjusting a pump rate of the dialysate inlet pump or the dialysate outlet pump to achieve a balanced flow rate through the inlet fluid flow pathway and the outlet fluid flow pathway; andafter the adjusting step, controlling the pump rate of the dialysate inlet pump or the dialysate outlet pump to pump fluid from the dialysate inlet pump through the inlet fluid flow pathway to the dialyzer at an inlet flow rate and through the outlet fluid flow pathway to the dialysate outlet pump from the dialyzer at an outlet flow rate different than the inlet flow rate.
  • 2. The method of claim 1 wherein the adjusting step comprises adjusting the pump rate of the dialysate inlet pump or the dialysate outlet pump so that the pressure of the fluid in the inlet fluid flow pathway is equal to the pressure of the fluid in the outlet fluid flow pathway.
  • 3. The method of claim 1 wherein the adjusting step comprises adjusting the pump rate such that pump rates of the dialysate inlet pump and the dialysate outlet pump are equal.
  • 4. The method of claim 1 further comprising: performing the step of flowing fluid from the dialysate inlet pump through the dialyzer to the dialysate outlet pump for 60 minutes;after the performing step, flowing fluid from the dialysate inlet pump through the bypass fluid flow pathway to the dialysis outlet pump;comparing pressure of the fluid in the inlet fluid flow pathway to pressure of the fluid in the outlet fluid flow pathway;based on a result of the comparing step, adjusting the pump rate of the dialysate inlet pump or the dialysate outlet pump to achieve a balanced flow rate through the inlet fluid flow pathway and the outlet fluid flow pathway; andafter the adjusting step, controlling the pump rate of the dialysate inlet pump or the dialysate outlet pump to pump fluid from the dialysate inlet pump through the inlet fluid flow pathway to the dialyzer at an inlet flow rate and through the outlet fluid flow pathway to the dialysate outlet pump from the dialyzer at an outlet flow rate different than the inlet flow rate.
  • 5. A method of calibrating a dialysis system comprising a dialyzer, a dialysate inlet pump, an inlet fluid flow pathway extending from the dialysate inlet pump to the dialyzer, a dialysate outlet pump, an outlet fluid flow pathway extending from the dialyzer to the dialysate outlet pump, the dialysate outlet pump being the only pump positioned for pumping dialysate out of and away from the dialyzer through the outlet fluid flow pathway, a bypass fluid flow pathway extending from the inlet fluid flow pathway to the outlet fluid flow pathway and bypassing the dialyzer, the method comprising: flowing fluid from the dialysate inlet pump through the bypass fluid flow pathway to the dialysis outlet pump;sensing pressure of the flowing fluid;based on a result of the sensing step, adjusting a pump rate of the dialysate inlet pump or the dialysate outlet pump to achieve a balanced flow rate through the inlet fluid flow pathway and the outlet fluid flow pathway; andafter the adjusting step, controlling the pump rate of the dialysate inlet pump or the dialysate outlet pump to pump fluid from the dialysate inlet pump through the inlet fluid flow pathway to the dialyzer at an inlet flow rate and through the outlet fluid flow pathway to the dialysate outlet pump from the dialyzer at an outlet flow rate different than the inlet flow rate.
  • 6. The method of claim 5 wherein the adjusting step comprises adjusting the pump rate of the dialysate inlet pump or the dialysate outlet pump so that the pressure of the fluid in the inlet fluid flow pathway is equal to the pressure of the fluid in the outlet fluid flow pathway.
  • 7. The method of claim 5 wherein the adjusting step comprises adjusting the pump rate such that pump rates of the dialysate inlet pump and the dialysate outlet pump are equal.
  • 8. The method of claim 5 further comprising: performing the step of flowing fluid from the dialysate inlet pump through the dialyzer to the dialysate outlet pump for 60 minutes;after the performing step, flowing fluid from the dialysate inlet pump through the bypass fluid flow pathway to the dialysis outlet pump;sensing the pressure of the flowing fluid;based on a result of the sensing step, adjusting the pump rate of the dialysate inlet pump or the dialysate outlet pump to achieve a balanced flow rate through the inlet fluid flow pathway and the outlet fluid flow pathway; andafter the adjusting step, controlling the pump rate of the dialysate inlet pump or the dialysate outlet pump to pump fluid from the dialysate inlet pump through the inlet fluid flow pathway to the dialyzer at an inlet flow rate and through the outlet fluid flow pathway to the dialysate outlet pump from the dialyzer at an outlet flow rate different than the inlet flow rate.
  • 9. A method of calibrating a dialysis system comprising a dialyzer, a dialysate inlet pump, an inlet fluid flow pathway extending from the dialysate inlet pump to the dialyzer, a dialysate outlet pump, an outlet fluid flow pathway extending from the dialyzer to the dialysate outlet pump, a bypass fluid flow pathway extending from the inlet fluid flow pathway to the outlet fluid flow pathway and bypassing the dialyzer, and a drain, the system having no control bag between the dialyzer and the drain, the method comprising: flowing fluid from the dialysate inlet pump through the bypass fluid flow pathway to the dialysis outlet pump;sensing pressure of the flowing fluid;based on a result of the sensing step, adjusting a pump rate of the dialysate inlet pump or the dialysate outlet pump to achieve a balanced flow rate through the inlet fluid flow pathway and the outlet fluid flow pathway; andafter the adjusting step, controlling the pump rate of the dialysate inlet pump or the dialysate outlet pump to pump fluid from the dialysate inlet pump through the inlet fluid flow pathway to the dialyzer at an inlet flow rate and through the outlet fluid flow pathway to the dialysate outlet pump from the dialyzer at an outlet flow rate different than the inlet flow rate.
  • 10. The method of claim 9 wherein the adjusting step further comprises balancing a flow rate from the dialysate inlet pump with a flow rate of the dialysate outlet pump.
  • 11. The method of claim 9 wherein the adjusting step comprises adjusting the pump rate of the dialysate inlet pump or the dialysate outlet pump so that the pressure of the fluid in the inlet fluid flow pathway is equal to the pressure of the fluid in the outlet fluid flow pathway.
  • 12. The method of claim 9 wherein the adjusting step comprises adjusting the pump rate such that pump rates of the dialysate inlet pump and the dialysate outlet pump are equal.
  • 13. The method of claim 9 further comprising: performing the step of flowing fluid from the dialysate inlet pump through the dialyzer to the dialysate outlet pump for 60 minutes;after the performing step, flowing fluid from the dialysate inlet pump through the bypass fluid flow pathway to the dialysis outlet pump;comparing the pressure of the fluid in the inlet fluid flow pathway to the value of the characteristic of the fluid in the outlet fluid flow pathway;based on a result of the comparing step, adjusting the pump rate of the dialysate inlet pump or the dialysate outlet pump to achieve a balanced flow rate through the inlet fluid flow pathway and the outlet fluid flow pathway; andafter the adjusting step, controlling the pump rate of the dialysate inlet pump or the dialysate outlet pump to pump fluid from the dialysate inlet pump through the inlet fluid flow pathway at an inlet flow rate to the dialyzer and through the outlet fluid flow pathway to the dialysate outlet pump from the dialyzer at an outlet flow rate different than the inlet flow rate.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 14/305,952, filed Jun. 16, 2014, which is a continuation of U.S. application Ser. No. 12/795,498, filed Jun. 7, 2010, now U.S. Pat. No. 8,753,515, that in turn claims priority to U.S. Provisional Application No. 61/267,043, filed Dec. 5, 2009. Priority of the filing date of Dec. 5, 2009, is hereby claimed, and the disclosures of the aforementioned patent applications are hereby incorporated by reference, each in its entirety.

US Referenced Citations (635)
Number Name Date Kind
3356360 Ward Dec 1967 A
3695445 Esmond Oct 1972 A
3710237 Watson et al. Jan 1973 A
3762032 Bowling et al. Oct 1973 A
3809309 Batista May 1974 A
3827563 Boe et al. Aug 1974 A
3965008 Dawson Jun 1976 A
4080295 Riede Mar 1978 A
4089456 Toppen et al. May 1978 A
4100068 Jordan et al. Jul 1978 A
4110220 Lavender Aug 1978 A
4115273 Winstead Sep 1978 A
4155157 Gersbacher May 1979 A
4172033 Willock Oct 1979 A
4194014 Hermans et al. Mar 1980 A
4204628 Houston et al. May 1980 A
4209391 Lipps Jun 1980 A
4229299 Savitz et al. Oct 1980 A
4231366 Schael Nov 1980 A
4267040 Schal May 1981 A
4293409 Riede et al. Oct 1981 A
4310416 Tanaka et al. Jan 1982 A
4317725 Kume et al. Mar 1982 A
4342651 Ahrens Aug 1982 A
4476022 Doll Oct 1984 A
4486303 Brous Dec 1984 A
4500426 Ishii et al. Feb 1985 A
4508622 Polaschegg Apr 1985 A
4536201 Brorsson et al. Aug 1985 A
4624784 Lefebvre Nov 1986 A
4647748 Glassman Mar 1987 A
4661246 Ash Apr 1987 A
4689108 Barry, Jr. et al. Aug 1987 A
4756835 Wilson Jul 1988 A
4769134 Allan et al. Sep 1988 A
4770787 Heath et al. Sep 1988 A
4773991 Aid Sep 1988 A
4786411 Benattar et al. Nov 1988 A
4827430 Aid et al. May 1989 A
4869421 Norris et al. Sep 1989 A
4875619 Anderson et al. Oct 1989 A
4889635 Chevallet Dec 1989 A
4894164 Polaschegg Jan 1990 A
4923613 Chevallet May 1990 A
5087930 Roy et al. Feb 1992 A
5092836 Polaschegg Mar 1992 A
5094749 Seita et al. Mar 1992 A
5147605 Tatsuno et al. Sep 1992 A
5227049 Chevallet et al. Jul 1993 A
5232145 Alley et al. Aug 1993 A
5236476 Klick Aug 1993 A
5247434 Peterson et al. Sep 1993 A
5259961 Eigendorf Nov 1993 A
5312550 Hester May 1994 A
5313023 Johnson May 1994 A
5316676 Drori May 1994 A
5326476 Grogan et al. Jul 1994 A
5342326 Peppel et al. Aug 1994 A
5344392 Senninger et al. Sep 1994 A
5346472 Keshaviah et al. Sep 1994 A
5360395 Utterberg Nov 1994 A
5385623 Diaz Jan 1995 A
5394732 Johnson et al. Mar 1995 A
5395351 Munsch Mar 1995 A
5401238 Pirazzoli Mar 1995 A
5409612 Maltais et al. Apr 1995 A
5421208 Packard et al. Jun 1995 A
5439451 Collinson et al. Aug 1995 A
5469264 Shigemori Nov 1995 A
5472614 Rossi Dec 1995 A
5489385 Raabe et al. Feb 1996 A
5498253 Aswad et al. Mar 1996 A
5498338 Kruger et al. Mar 1996 A
5503624 Roeher et al. Apr 1996 A
5520640 Utterberg May 1996 A
5526357 Jandrell Jun 1996 A
5533996 Murphey et al. Jul 1996 A
5534328 Ashmead et al. Jul 1996 A
5536258 Folden Jul 1996 A
5580460 Polaschegg Dec 1996 A
5580523 Bard Dec 1996 A
5582600 Loh Dec 1996 A
5591016 Kubota et al. Jan 1997 A
5591344 Kenley et al. Jan 1997 A
5593581 Lescoche Jan 1997 A
5595712 Harbster et al. Jan 1997 A
5609770 Zimmerman et al. Mar 1997 A
5610645 Moore et al. Mar 1997 A
5611214 Wegeng et al. Mar 1997 A
5613663 Schmidt et al. Mar 1997 A
5615996 Suzuki et al. Apr 1997 A
5618268 Raines et al. Apr 1997 A
5618441 Rosa et al. Apr 1997 A
5620608 Rosa et al. Apr 1997 A
5623969 Raines Apr 1997 A
5624572 Larson et al. Apr 1997 A
5629871 Love et al. May 1997 A
5630804 Imada et al. May 1997 A
5643190 Utterberg Jul 1997 A
5647984 Hovland et al. Jul 1997 A
5648684 Bertin et al. Jul 1997 A
5650071 Brugger et al. Jul 1997 A
5662144 Lo et al. Sep 1997 A
5685835 Brugger Nov 1997 A
5689966 Zess et al. Nov 1997 A
5693008 Brugger et al. Dec 1997 A
5698916 Eguchi Dec 1997 A
5711883 Folden et al. Jan 1998 A
5713850 Heilmann et al. Feb 1998 A
5725773 Polaschegg Mar 1998 A
5743892 Loh et al. Apr 1998 A
5744031 Bene Apr 1998 A
5749226 Bowman et al. May 1998 A
5769985 Kawakami et al. Jun 1998 A
5779833 Cawley et al. Jul 1998 A
5782575 Vincent et al. Jul 1998 A
5788099 Treu et al. Aug 1998 A
5788851 Kenley et al. Aug 1998 A
5792367 Mattisson et al. Aug 1998 A
5811062 Wegeng et al. Sep 1998 A
5813235 Peterson Sep 1998 A
5851202 Carlsson Dec 1998 A
5858238 Mcrea et al. Jan 1999 A
5858239 Kenley et al. Jan 1999 A
5861555 Hobro et al. Jan 1999 A
5868930 Kopf Feb 1999 A
5879316 Safar et al. Mar 1999 A
5881774 Utterberg Mar 1999 A
5885456 Charkoudian et al. Mar 1999 A
5895368 Utterberg Apr 1999 A
5903211 Flego et al. May 1999 A
5910138 Sperko et al. Jun 1999 A
5914033 Carlsson Jun 1999 A
5921678 Desai et al. Jul 1999 A
5928177 Brugger et al. Jul 1999 A
5928180 Krivitski et al. Jul 1999 A
5932103 Kenley et al. Aug 1999 A
5932940 Epstein et al. Aug 1999 A
5938634 Packard Aug 1999 A
5938938 Bosetto et al. Aug 1999 A
5951870 Utterberg Sep 1999 A
5957898 Jepson et al. Sep 1999 A
5974867 Forster et al. Nov 1999 A
5976115 Parris et al. Nov 1999 A
5983947 Utterberg Nov 1999 A
5984903 Nadal Nov 1999 A
5993174 Konishi Nov 1999 A
6003556 Brugger et al. Dec 1999 A
6010623 Schnell et al. Jan 2000 A
6024276 Hirata et al. Feb 2000 A
6032926 Fuchs Mar 2000 A
6036680 Horne et al. Mar 2000 A
6039877 Chevallet et al. Mar 2000 A
6041801 Gray et al. Mar 2000 A
6044691 Kenley et al. Apr 2000 A
6048432 Ecer Apr 2000 A
6058934 Sullivan May 2000 A
6064797 Crittendon et al. May 2000 A
6066261 Spickermann May 2000 A
6071269 Schnell et al. Jun 2000 A
6074559 Hahmann et al. Jun 2000 A
6077443 Goldau Jun 2000 A
6082891 Schubert et al. Jul 2000 A
6100463 Ladd et al. Aug 2000 A
6109994 Cho et al. Aug 2000 A
6113785 Miura et al. Sep 2000 A
6117115 Hill et al. Sep 2000 A
6117123 Barney et al. Sep 2000 A
6121539 Johnson et al. Sep 2000 A
6123798 Gandhi et al. Sep 2000 A
6126723 Drost et al. Oct 2000 A
6126831 Goldau et al. Oct 2000 A
6129973 Martin et al. Oct 2000 A
6132616 Twardowski et al. Oct 2000 A
6139754 Hartranft et al. Oct 2000 A
6142008 Cole et al. Nov 2000 A
6143181 Falkvall et al. Nov 2000 A
6143247 Sheppard et al. Nov 2000 A
6148635 Beebe et al. Nov 2000 A
6153102 Kenley et al. Nov 2000 A
6165149 Utterberg et al. Dec 2000 A
6165161 York et al. Dec 2000 A
6167910 Chow Jan 2001 B1
6187198 Utterberg Feb 2001 B1
6187199 Goldau Feb 2001 B1
6192596 Bennett et al. Feb 2001 B1
6193462 Kubota Feb 2001 B1
6202312 Rando Mar 2001 B1
6203522 Holmberg et al. Mar 2001 B1
6203535 Barney et al. Mar 2001 B1
6212333 Olk et al. Apr 2001 B1
6220299 Arvidsson et al. Apr 2001 B1
6221040 Kleinekofort Apr 2001 B1
6221064 Nadal Apr 2001 B1
6223130 Gray et al. Apr 2001 B1
6225497 Becker et al. May 2001 B1
6234773 Hill et al. May 2001 B1
6251279 Peterson et al. Jun 2001 B1
6254567 Treu et al. Jul 2001 B1
6254754 Ross et al. Jul 2001 B1
6258276 Mika et al. Jul 2001 B1
6261282 Jepson et al. Jul 2001 B1
6277277 Jacobi et al. Aug 2001 B1
6280406 Dolecek et al. Aug 2001 B1
6284141 Shaldon et al. Sep 2001 B1
6302653 Bryant et al. Oct 2001 B1
6308721 Bock et al. Oct 2001 B1
6309673 Duponchelle et al. Oct 2001 B1
6322551 Brugger Nov 2001 B1
6323662 Ferri Nov 2001 B2
6325774 Bene et al. Dec 2001 B1
6329139 Nova et al. Dec 2001 B1
6331252 El Sayyid et al. Dec 2001 B1
6334301 Otsap et al. Jan 2002 B1
6343614 Gray et al. Feb 2002 B1
6344033 Jepson et al. Feb 2002 B1
6346084 Schnell et al. Feb 2002 B1
6347711 Goebel et al. Feb 2002 B1
6349170 Fressinet et al. Feb 2002 B1
6350260 Goebel et al. Feb 2002 B1
6355161 Shah et al. Mar 2002 B1
6357332 Vecchio Mar 2002 B1
6365041 Hoadley Apr 2002 B1
6368505 Grummert et al. Apr 2002 B1
6375871 Bentsen et al. Apr 2002 B1
6382923 Gray May 2002 B1
6387069 Utterberg May 2002 B1
6395180 Chioini et al. May 2002 B2
6415860 Kelly et al. Jul 2002 B1
6416293 Bouchard et al. Jul 2002 B1
6423022 Roeher et al. Jul 2002 B1
6432309 Fuke et al. Aug 2002 B1
6454736 Ludt et al. Sep 2002 B1
6454942 Shintani et al. Sep 2002 B1
6468056 Murakoshi Oct 2002 B1
6477058 Luebs et al. Nov 2002 B1
6481982 Yokomichi Nov 2002 B1
6485263 Bryant et al. Nov 2002 B1
6488842 Nagaoka Dec 2002 B2
6488872 Beebe et al. Dec 2002 B1
6503062 Gray et al. Jan 2003 B1
6514225 Utterberg et al. Feb 2003 B1
6514412 Insley et al. Feb 2003 B1
6526357 Soussan et al. Feb 2003 B1
6527728 Zhang Mar 2003 B2
6530262 Esser Mar 2003 B1
6536742 Lotz et al. Mar 2003 B2
6537506 Schwalbe et al. Mar 2003 B1
6544229 Danby et al. Apr 2003 B1
6546998 Oh et al. Apr 2003 B2
6554789 Brugger et al. Apr 2003 B1
6572576 Brugger et al. Jun 2003 B2
6572641 Brugger et al. Jun 2003 B2
6575927 Weitzel et al. Jun 2003 B1
6579241 Roeher Jun 2003 B2
6579253 Burbank et al. Jun 2003 B1
6581906 Pott et al. Jun 2003 B2
6582385 Burbank et al. Jun 2003 B2
6592558 Quah Jul 2003 B2
6601432 Ericson et al. Aug 2003 B1
6602424 Krämer et al. Aug 2003 B1
6604908 Bryant et al. Aug 2003 B1
6607644 Apffel, Jr. Aug 2003 B1
6607697 Müller Aug 2003 B1
6616877 Close et al. Sep 2003 B2
6616909 Tonkovich et al. Sep 2003 B1
6623860 Hu et al. Sep 2003 B2
6630068 Vinci Oct 2003 B1
6635226 Tso et al. Oct 2003 B1
6640611 Ericson et al. Nov 2003 B2
6649046 Chevallet Nov 2003 B2
6649063 Brugger et al. Nov 2003 B2
6652627 Tonkovich et al. Nov 2003 B1
6653841 Koerdt et al. Nov 2003 B1
6654660 Singh et al. Nov 2003 B1
6666840 Falkvall et al. Dec 2003 B1
6666909 Tegrotenhuis et al. Dec 2003 B1
6672502 Paul et al. Jan 2004 B1
6673311 Sotoyama et al. Jan 2004 B1
6676621 Menninger Jan 2004 B1
6676835 O'Connor et al. Jan 2004 B2
6684710 Chevallet et al. Feb 2004 B2
6685831 Dönig et al. Feb 2004 B2
6686946 Masuda et al. Feb 2004 B2
6688381 Pence et al. Feb 2004 B2
6695807 Bell et al. Feb 2004 B2
6716356 Collins et al. Apr 2004 B2
6730233 Pedrazzi May 2004 B2
6731216 Ho et al. May 2004 B2
6733676 Takai May 2004 B2
6736789 Spickermann May 2004 B1
6738052 Manke et al. May 2004 B1
6743193 Brugger et al. Jun 2004 B2
6744038 Wang et al. Jun 2004 B2
6746514 Bedingfield et al. Jun 2004 B2
6749814 Bergh et al. Jun 2004 B1
6767333 Müller et al. Jul 2004 B1
6775577 Crnkovich et al. Aug 2004 B2
6793831 Paul et al. Sep 2004 B1
6797056 David Sep 2004 B2
6804991 Balschat et al. Oct 2004 B2
6806947 Ekdahl et al. Oct 2004 B1
6811707 Rovatti et al. Nov 2004 B2
6814547 Childers et al. Nov 2004 B2
6814726 Lauer Nov 2004 B1
6814859 Koehler et al. Nov 2004 B2
6818179 Edgson et al. Nov 2004 B1
6821432 Metzner Nov 2004 B2
6827698 Kleinekofort Dec 2004 B1
6830693 Govoni et al. Dec 2004 B2
6838156 Neyer et al. Jan 2005 B1
6852231 Ivansons et al. Feb 2005 B2
6858137 Hahmann et al. Feb 2005 B2
6863867 Vanden Bussche et al. Mar 2005 B2
6868309 Begelman Mar 2005 B1
6869538 Yu et al. Mar 2005 B2
6871838 Raines et al. Mar 2005 B2
6877713 Gray et al. Apr 2005 B1
6878283 Thompson Apr 2005 B2
6880034 Manke et al. Apr 2005 B2
6881344 Vasta et al. Apr 2005 B2
6889556 Steger May 2005 B2
6892781 Mcherron et al. May 2005 B2
6903332 Weiss et al. Jun 2005 B2
6905479 Bouchard et al. Jun 2005 B1
6911262 Sallavanti et al. Jun 2005 B2
6913877 Chaplen et al. Jul 2005 B1
6929751 Bowman, Jr. et al. Aug 2005 B2
6936031 Caleffi Aug 2005 B2
6939111 Huitt et al. Sep 2005 B2
6939471 Gross et al. Sep 2005 B2
6952963 Delnevo Oct 2005 B2
6953323 Childers et al. Oct 2005 B2
6955655 Burbank et al. Oct 2005 B2
6967002 Edgson et al. Nov 2005 B1
6974301 Suzuki et al. Dec 2005 B2
6976964 Chevallet et al. Dec 2005 B2
6979309 Burbank et al. Dec 2005 B2
6981522 O'Connor et al. Jan 2006 B2
6986428 Hester et al. Jan 2006 B2
6989134 Tonkovich et al. Jan 2006 B2
6994829 Whyatt et al. Feb 2006 B2
7004924 Brugger et al. Feb 2006 B1
7014705 David Mar 2006 B2
7021148 Kuhn et al. Apr 2006 B2
7022098 Wariar et al. Apr 2006 B2
7029456 Ware et al. Apr 2006 B2
7033498 Wong Apr 2006 B2
7033539 Krensky et al. Apr 2006 B2
7040142 Burbank May 2006 B2
7044432 Beden et al. May 2006 B2
7044927 Mueller et al. May 2006 B2
7063512 Haesloop et al. Jun 2006 B2
7070589 Lolachi et al. Jul 2006 B2
7074191 Bosetto et al. Jul 2006 B2
7087033 Brugger et al. Aug 2006 B2
7087036 Busby et al. Aug 2006 B2
7094345 Gilbert et al. Aug 2006 B2
7112273 Weigel et al. Sep 2006 B2
7114701 Peppel Oct 2006 B2
7115206 Chevallet et al. Oct 2006 B2
7115228 Lundtveit et al. Oct 2006 B2
7118920 Brophy et al. Oct 2006 B2
7121815 Knuth et al. Oct 2006 B2
7122149 Li et al. Oct 2006 B2
7122156 Bergh et al. Oct 2006 B2
7125540 Wegeng et al. Oct 2006 B1
7131956 Pirazzoli et al. Nov 2006 B1
7147615 Wariar et al. Dec 2006 B2
7150815 Ashmead et al. Dec 2006 B2
7152469 Milleker et al. Dec 2006 B2
7163531 Seese et al. Jan 2007 B2
7166084 Utterberg Jan 2007 B2
7168334 Drott Jan 2007 B1
7170591 Ohishi et al. Jan 2007 B2
7175697 Neri Feb 2007 B2
7186342 Pirazzoli et al. Mar 2007 B2
7188151 Kumar et al. Mar 2007 B2
7211442 Gilbert et al. May 2007 B2
7214312 Brugger et al. May 2007 B2
7217108 Herwig et al. May 2007 B2
7217364 Lauer et al. May 2007 B2
7223262 Brehm et al. May 2007 B2
7223338 Duchamp et al. May 2007 B2
7232418 Neri et al. Jun 2007 B2
7238164 Childers et al. Jul 2007 B2
7247146 Tonelli et al. Jul 2007 B2
7279134 Chan et al. Oct 2007 B2
7291123 Baraldi et al. Nov 2007 B2
7306197 Parrino et al. Dec 2007 B2
7314061 Peppel Jan 2008 B2
7316780 Fendya et al. Jan 2008 B1
7337674 Burbank et al. Mar 2008 B2
7341568 Zhang Mar 2008 B2
7354426 Young Apr 2008 B2
7355685 Scibona et al. Apr 2008 B2
7378280 Quake et al. May 2008 B2
7381195 Mori et al. Jun 2008 B2
7393337 Tonelli et al. Jul 2008 B2
7402249 Ikeda Jul 2008 B2
7469716 Parrino et al. Dec 2008 B2
7470265 Brugger et al. Dec 2008 B2
7488301 Beden et al. Feb 2009 B2
7488447 Sternby Feb 2009 B2
7493824 Brucksch et al. Feb 2009 B2
7494590 Felding et al. Feb 2009 B2
7503908 Bartholomew Mar 2009 B2
7507380 Chang et al. Mar 2009 B2
7510545 Peppel Mar 2009 B2
7517332 Tonelli et al. Apr 2009 B2
7517387 Chevallet et al. Apr 2009 B2
7520919 Caleffi Apr 2009 B2
7537687 Toyoda et al. May 2009 B2
7544300 Brugger et al. Jun 2009 B2
7551043 Nguyen et al. Jun 2009 B2
7559911 Giannella Jul 2009 B2
7575562 Oishi et al. Aug 2009 B2
7575564 Childers Aug 2009 B2
7591449 Raines et al. Sep 2009 B2
7603907 Reiter et al. Oct 2009 B2
7615035 Peppel Nov 2009 B2
7618531 Sugioka et al. Nov 2009 B2
7622043 Sawada et al. Nov 2009 B2
7632470 Tabata et al. Dec 2009 B2
7647834 O'Mahony et al. Jan 2010 B2
7648474 Paolini et al. Jan 2010 B2
7648476 Bock et al. Jan 2010 B2
7648792 Kaschmitter et al. Jan 2010 B2
7656527 Scarpaci Feb 2010 B2
7661294 Dam Feb 2010 B2
7671974 O'Mahony et al. Mar 2010 B2
7682328 Han et al. Mar 2010 B2
7686778 Burbank et al. Mar 2010 B2
7699992 Sternby Apr 2010 B2
7708714 Connell et al. May 2010 B2
7713226 Ash et al. May 2010 B2
7726361 Bartholomew Jun 2010 B2
7727220 Wieslander et al. Jun 2010 B2
7744553 Kelly et al. Jun 2010 B2
7749184 Cavalcanti et al. Jul 2010 B2
7758082 Weigel et al. Jul 2010 B2
7758547 Tonelli et al. Jul 2010 B2
7771379 Treu Aug 2010 B2
7771380 Jönsson et al. Aug 2010 B2
7775986 Roeher et al. Aug 2010 B2
7776219 Brugger et al. Aug 2010 B2
7780848 Kim et al. Aug 2010 B2
7788038 Oshita et al. Aug 2010 B2
7790029 Dannenmaier et al. Sep 2010 B2
7794141 Perry et al. Sep 2010 B2
7794419 Paolini et al. Sep 2010 B2
7801746 Moll et al. Sep 2010 B2
7815852 Sternby Oct 2010 B2
7824354 Vinci et al. Nov 2010 B2
7873489 Dolgos et al. Jan 2011 B2
7896831 Sternby et al. Mar 2011 B2
7901579 Brugger et al. Mar 2011 B2
7913751 Zwittig Mar 2011 B2
7918993 Harraway Apr 2011 B2
7922899 Vasta et al. Apr 2011 B2
7955504 Jovanovic et al. Jun 2011 B1
7968250 Kaschmitter et al. Jun 2011 B2
8002727 Brugger et al. Aug 2011 B2
8012114 Daniel et al. Sep 2011 B2
8075509 Molducci et al. Dec 2011 B2
8105265 Demers et al. Jan 2012 B2
8128822 Browning et al. Mar 2012 B2
8137554 Jovanovic et al. Mar 2012 B2
8182440 Cruz et al. May 2012 B2
8182691 Stahl May 2012 B2
8190651 Treu et al. May 2012 B2
8192387 Brugger et al. Jun 2012 B2
8210049 Brugger Jul 2012 B2
8235931 Burbank et al. Aug 2012 B2
8236599 Chang et al. Aug 2012 B2
8267881 O'Mahony et al. Sep 2012 B2
8273245 Jovanovic et al. Sep 2012 B2
8293113 Jönsson et al. Oct 2012 B2
8293114 Jönsson et al. Oct 2012 B2
8298427 Ficheux et al. Oct 2012 B2
8323492 Childers et al. Dec 2012 B2
8329030 Childers et al. Dec 2012 B2
8343085 Toyoda et al. Jan 2013 B2
8394046 Nuernberger et al. Mar 2013 B2
8414182 Paul et al. Apr 2013 B2
8419945 Browning et al. Apr 2013 B2
8449487 Hovland et al. May 2013 B2
8460228 Burbank et al. Jun 2013 B2
8475398 O'Mahony Jul 2013 B2
8491518 Schnell et al. Jul 2013 B2
8496824 Remkes et al. Jul 2013 B2
8501009 Peterson et al. Aug 2013 B2
8506536 Schnell Aug 2013 B2
8512553 Cicchello et al. Aug 2013 B2
8512554 Yu et al. Aug 2013 B2
8524086 Peterson et al. Sep 2013 B2
8529491 Beiriger Sep 2013 B2
8603020 Roger et al. Dec 2013 B2
8608658 Burbank et al. Dec 2013 B2
8647290 Masala et al. Feb 2014 B2
8679348 Burbank et al. Mar 2014 B2
8685251 Smejtek et al. Apr 2014 B2
8753515 Curtis et al. Jun 2014 B2
8801922 Wrazel et al. Aug 2014 B2
8840581 McGill et al. Sep 2014 B2
9024746 Burbank et al. May 2015 B2
9097370 Schnell et al. Aug 2015 B2
9138687 Peterson et al. Sep 2015 B2
9328969 Wrazel et al. May 2016 B2
9402945 Hogard et al. Aug 2016 B2
20020023879 Hadden Feb 2002 A1
20020032398 Steele et al. Mar 2002 A1
20020108859 Wang et al. Aug 2002 A1
20020108869 Savtchenko Aug 2002 A1
20020115200 Zou et al. Aug 2002 A1
20020162784 Kohlheb et al. Nov 2002 A1
20020187069 Levin et al. Dec 2002 A1
20030010717 Brugger et al. Jan 2003 A1
20030039169 Ehrfeld et al. Feb 2003 A1
20030052429 Vigna et al. Mar 2003 A1
20030082066 Hajaligol et al. May 2003 A1
20030138349 Robinson et al. Jul 2003 A1
20030156991 Halas et al. Aug 2003 A1
20030163077 Kim et al. Aug 2003 A1
20030183345 Soberay Oct 2003 A1
20030220598 Busby et al. Nov 2003 A1
20040004589 Shih Jan 2004 A1
20040008370 Keane et al. Jan 2004 A1
20040012122 Nagaoka et al. Jan 2004 A1
20040016700 Kellam et al. Jan 2004 A1
20040020286 Blakley et al. Feb 2004 A1
20040022691 Allen et al. Feb 2004 A1
20040035452 Ma Feb 2004 A1
20040035462 McCarty et al. Feb 2004 A1
20040072278 Chou et al. Apr 2004 A1
20040084370 Singh et al. May 2004 A1
20040084371 Kellam et al. May 2004 A1
20040086427 Childers et al. May 2004 A1
20040125689 Ehrfeld et al. Jul 2004 A1
20040157096 Peterson Aug 2004 A1
20040158189 Tonelli et al. Aug 2004 A1
20040208751 Lazar et al. Oct 2004 A1
20040215129 Edgson et al. Oct 2004 A1
20040256230 Yager et al. Dec 2004 A1
20050006296 Sullivan et al. Jan 2005 A1
20050007748 Callahan et al. Jan 2005 A1
20050070837 Ferrarini et al. Mar 2005 A1
20050074834 Chaplen et al. Apr 2005 A1
20050082225 Kreymann Apr 2005 A1
20050126211 Drost et al. Jun 2005 A1
20050129580 Swinehart et al. Jun 2005 A1
20050131332 Kelly et al. Jun 2005 A1
20050145497 Gilbert et al. Jul 2005 A1
20050179748 Malik et al. Aug 2005 A1
20050202557 Borenstein et al. Sep 2005 A1
20060079698 Joshi et al. Apr 2006 A1
20060157413 Bene et al. Jul 2006 A1
20060200064 Gross et al. Sep 2006 A1
20060266692 Foster et al. Nov 2006 A1
20070020400 Chang Jan 2007 A1
20070029365 Paul et al. Feb 2007 A1
20070119771 Schukar et al. May 2007 A1
20070125489 Paul et al. Jun 2007 A1
20070128707 Rorrer et al. Jun 2007 A1
20070131403 Vetrovec et al. Jun 2007 A1
20070158249 Ash Jul 2007 A1
20070158268 Decomo Jul 2007 A1
20070184576 Chang et al. Aug 2007 A1
20070215644 Otis et al. Sep 2007 A1
20070278155 Lo et al. Dec 2007 A1
20070295651 Martinez et al. Dec 2007 A1
20080006040 Peterson et al. Jan 2008 A1
20080009780 Leonard et al. Jan 2008 A1
20080097274 Neri et al. Apr 2008 A1
20080108122 Paul et al. May 2008 A1
20080108930 Weitzel et al. May 2008 A1
20080149563 Ash Jun 2008 A1
20080196725 Mele Aug 2008 A1
20080200858 Ichiishi et al. Aug 2008 A1
20080296226 Gotch Dec 2008 A1
20090008331 Wilt et al. Jan 2009 A1
20090012452 Slepicka et al. Jan 2009 A1
20090038393 Chaung et al. Feb 2009 A1
20090087326 Voltenburg et al. Apr 2009 A1
20090092526 Miller Apr 2009 A1
20090095679 Demers et al. Apr 2009 A1
20090101549 Kamen et al. Apr 2009 A1
20090101576 Rohde et al. Apr 2009 A1
20090114595 Wallenas et al. May 2009 A1
20090124963 Hogard et al. May 2009 A1
20090165366 Jovanovic et al. Jul 2009 A1
20090211977 Miller Aug 2009 A1
20090306573 Gagner et al. Dec 2009 A1
20090309835 Levin et al. Dec 2009 A1
20100018923 Rohde et al. Jan 2010 A1
20100022934 Hogard Jan 2010 A1
20100051552 Rohde et al. Mar 2010 A1
20100078385 Kawarabata et al. Apr 2010 A1
20100192686 Kamen et al. Aug 2010 A1
20100271296 Kopychev et al. Oct 2010 A1
20100292627 Caleffi et al. Nov 2010 A1
20100292657 Fontanazzi et al. Nov 2010 A1
20100321046 Randall et al. Dec 2010 A1
20100326914 Drost et al. Dec 2010 A1
20110005986 Kelly et al. Jan 2011 A1
20110105979 Schlaeper et al. May 2011 A1
20110106466 Furmanski et al. May 2011 A1
20110132841 Rohde et al. Jun 2011 A1
20110186517 Hedmann et al. Aug 2011 A1
20110189048 Curtis et al. Aug 2011 A1
20110257579 Rossi et al. Oct 2011 A1
20110295175 Felder et al. Dec 2011 A1
20120029937 Neftel et al. Feb 2012 A1
20120065581 Childers et al. Mar 2012 A1
20120103902 Childers et al. May 2012 A1
20120138533 Curtis et al. Jun 2012 A1
20120292246 Jovanovic et al. Nov 2012 A1
20120318740 Ekdahl et al. Dec 2012 A1
20130018301 Weaver et al. Jan 2013 A1
20130020237 Wilt et al. Jan 2013 A1
20130056419 Curtis Mar 2013 A1
20130186829 Callan et al. Jul 2013 A1
20140021111 Roger et al. Jan 2014 A1
20140069861 Browning et al. Mar 2014 A1
20140209540 Smejtek et al. Jul 2014 A1
20140291243 Curtis et al. Oct 2014 A1
20140299545 Wrazel et al. Oct 2014 A1
20150314055 Hogard et al. Nov 2015 A1
20150328386 Peterson et al. Nov 2015 A1
20150343128 Hogard et al. Dec 2015 A1
20150343131 Hogard et al. Dec 2015 A1
20150343132 Hogard et al. Dec 2015 A1
20150343133 Hogard et al. Dec 2015 A1
20150354906 Miller Dec 2015 A1
20160082172 Miller et al. Mar 2016 A1
Foreign Referenced Citations (26)
Number Date Country
200951223 Sep 2007 CN
8702995 Jun 1987 DE
69217519 Jun 1997 DE
0165751 Dec 1985 EP
0324922 Jul 1989 EP
0679100 Nov 1995 EP
0796997 Sep 1997 EP
0547025 Jun 2002 EP
1289738 Sep 1972 GB
59-58002 Apr 1984 JP
60-143803 Jul 1985 JP
2002143298 May 2002 JP
2007268490 Oct 2007 JP
2007529707 Oct 2007 JP
WO0016916 Mar 2000 WO
WO0025843 May 2000 WO
WO0240874 May 2002 WO
WO02076529 Oct 2002 WO
WO03076661 Sep 2003 WO
WO2006039293 Apr 2006 WO
WO2007089855 Aug 2007 WO
WO2008027967 Mar 2008 WO
WO2008106191 Sep 2008 WO
WO2010027435 Mar 2010 WO
WO2010062698 Jun 2010 WO
WO2010085764 Jul 2010 WO
Non-Patent Literature Citations (24)
Entry
Allis et al., “Chapter 16: Nanostructural Architectures from Molecular Building Blocks,” in Handbook of Nanoscience, Engineering, and Technology, 1st Edition (Electrical Engineering Handbook), CRC Press LLC, Boca Raton, FL, Chapter 16 (70 pgs.), Oct. 2002.
Anglés et al., “Plasticized starch/Tunicin Whiskers Nanocomposite Materials. 2. Mechanical behavior,” Macromolecules, 34, pp. 2921-2931, Mar. 2001.
California Energy Commission; Development of Supported Polymeric Liquid Membrane Technology for Aqueous MTBE Mitigation, EPRI, Palo Alto, CA, California Energy Commission, Sacramento, CA: Doc. No. 1006577; 70 pgs.; Jul. 2002.
Demura et al., “Ductile Thin Foil of Ni3Al,” Mechanical Properties of Structural Films, ASTM International Nov. 2000 Symposium (Orlando, FL), pp. 248-261, published Oct. 1, 2001.
Favier et al.; Nanocomposite materials from latex and cellulose whiskers; Polymers for Advanced Technologies; 6; pp. 351-355; Jan. 1995.
Federal Energy Technology Center, “Technology Development Through Industrial Partnerships,” (Tech. Dev. Data Sheet), 12 pgs., Sep. 1998.
Grunert et al., “Progress in the Development of Cellulose Reinforced Nanocomposites,” PMSE Preprints 2000, 82, 232, 2 pgs., Mar. 2000.
Haas, “Further development of MMW and SMMW platelet feed horn arrays,” Astron. Soc. Pac. Conf. Ser., vol. 75, pp. 99-105, Multi-Feed Systems for Radio Telescopes, Workshop held in Tucson, Arizona, May 16-18, 1994.
Introtek International; Drip chamber liquid level sensor (sales literature); 2 pages; retrieved from the internet (http://www.introtek.com/PDFs/l/DDS-14.0—DripDetectSensor.pdf); © Jan. 1, 2009.
Koeneman et al., “Feasibility of Micro Power Supplies for MEMS,” (pre-publication copy) J. MicroElectoMechanical Sys., 6(4), pp. 355-362, Dec. 1997.
Morin et al., “Nanocomposites of Chitin Whiskers from Riftia Tubes and Poly (caprolactone),” Macromolecules, vol. 35, pp. 2190-2199, Feb. 2002.
Nakamura et al., “Research on Pressure Welding Conditions of Various Work Metals (Effects of Contact Pressure, Surface Expansion Ratio and Temperature),” JSME International Journal, Series III 31(3), 612-617, Sep. 1988.
Nakao et al., “Diffusion Bonding of Intermetallic Compound TiAl,” ISIJ International, 31(10), 1260-1266, Oct. 1991.
Oddy et al., “Electrokinetic Instability Micromixing,” Anal. Chem., 73(24), pp. 5822-5832, Dec. 2001.
Omega Engineering Inc.; Load Cell (definition, information); 3 pgs; retrieved from the internet on Jun. 17, 2015 (http://www.omega.com/prodinfo/LoadCells.html).
Orts et al., “Effect of Fiber Source on Cellulose Reinforced Polymer Nanocomposites,” ANTEC 2004: Conference Proceedings, 62nd Annual Tech. Conference; Chicago, IL, pp. 2427-2431, May 2004.
Paillet et al., “Chitin Whisker Reinforced Thermoplastic Nanocomposites,” Macromolecules, vol. 34, No. 19, pp. 6527-6530, Sep. 2001.
Paul et al., “Microlamination for Microtechnology-based Energy, Chemical, and Biological Systems,” ASME IMECE, ASE vol. 39, pp. 45-52, Nashville, Tennessee, Nov. 15-20, 1999.
Pluess, “Application of Controlled Thermal Expansion in Diffusion Bonding for the High-Volume Microlamination of MECS Devices,” Thesis (MS), Oregon State University, 193 pgs., Sep. 2004.
Porter et al.; Cost drivers in microlamination based on a high volume production system design; ASME 2002 Conf. Proc.; New Orleans, Louisiana; pp. 267-274; Nov. 17-22, 2002.
Sharma et al., “The Application of Surface Mount Technology to Multi-Scale Process Intensification,” ASPE, pp. 1-4, Oct. 2003.
Stroock et al., “Chaotic Mixer for Microchannels,” Science, 295, pp. 647-651, Jan. 2002.
Thorsen et al.; Microfluidic Large-Scale Integration; Science; 298; pp. 580-584; Oct. 18, 2002.
Wegeng et al., “Chemical system miniaturization,” Proceedings of the AIChE Spring National Meeting, pp. 1-13, Feb. 1996.
Related Publications (1)
Number Date Country
20160339162 A1 Nov 2016 US
Provisional Applications (1)
Number Date Country
61267043 Dec 2009 US
Continuations (2)
Number Date Country
Parent 14305952 Jun 2014 US
Child 15225712 US
Parent 12795498 Jun 2010 US
Child 14305952 US